Corrected: Roche is not moving forward with SQZ program, sending the biotech into strategic review
This story was corrected to note that Roche has elected not to take its option on SQZ’s program. A previous version said that Roche and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.